Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy

被引:1
作者
Bondi, Alessandro [1 ,2 ]
Koumantakis, Emanuele [2 ,3 ]
Curtoni, Antonio [1 ,2 ]
Barbui, Anna Maria [1 ]
Peradotto, Marco [1 ]
Lombardi, Daniela [4 ]
Casale, Roberto [2 ]
Alizzi, Silvia [1 ]
Zanotto, Elisa [1 ]
Charrier, Lorena [2 ]
Cavallo, Rossana [1 ,2 ]
Costa, Cristina [1 ,2 ]
机构
[1] AOU Citta Salute & Sci Torino, Microbiol & Virol Unit, I-10126 Turin, Italy
[2] Univ Turin, Dept Publ Hlth & Pediat, I-10126 Turin, Italy
[3] Univ Turin, Post Grad Sch Med Stat, I-10126 Turin, Italy
[4] Reg Epidemiol Reference Serv Surveillance Prevent, I-15121 Alessandria, Italy
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 08期
关键词
S; pneumoniae; anti-pneumococcal vaccination; antimicrobial resistance; CONJUGATE VACCINE; UNITED-STATES; SEROTYPES; SURVEILLANCE; ADULTS; SPAIN;
D O I
10.3390/antibiotics13080740
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The international surveillance of antimicrobial resistance (AMR) reports S. pneumoniae as one of leading causes of death associated with AMR. Against invasive disease, several vaccinations are available and a reduction in AMR in S. pneumoniae has been observed. Here, we evaluated the impact of anti-pneumococcal vaccination policy and the SARS-CoV2 outbreak on AMR in S. pneumoniae causing invasive disease. Methods: We collected all strains of S. pneumoniae causing invasive disease from 2008 in the Piedmont region (Italy). Each strain was typed in order to identify the serogroup and data about AMR were collected. The population under surveillance was classified as infants, children, adults, and the old population. Results: We collected n = 2076 S. pneumoniae strains, with 21.9% and 40.3% being resistant to penicillin G and erythromycin, respectively. We reported an increased risk of infection with penicillin-resistant S. pneumoniae among all populations and evaluated whether the infection was caused by a serotype included in the vaccine formulation. A similar increase was observed after the SARS-CoV2 outbreak. Conclusions: In the Piedmont region, subsequently to the introduction of anti-pneumococcal vaccination, a significant increase in the risk of penicillin G-resistant invasive pneumococcal disease among infants and old population was reported. No significant impact was found for the SARS-CoV2 outbreak.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis
    Adegbola, Richard A.
    DeAntonio, Rodrigo
    Hill, Philip C.
    Roca, Anna
    Usuf, Effua
    Hoet, Bernard
    Greenwood, Brian M.
    [J]. PLOS ONE, 2014, 9 (08):
  • [2] Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis
    Andrejko, Kristin
    Ratnasiri, Buddhika
    Hausdorff, William P.
    Laxminarayan, Ramanan
    Lewnard, Joseph A.
    [J]. LANCET MICROBE, 2021, 2 (09): : E450 - E460
  • [3] Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States
    Bajema, Kristina L.
    Gierke, Ryan
    Farley, Monica M.
    Schaffner, William
    Thomas, Ann
    Reingold, Arthur L.
    Harrison, Lee H.
    Lynfield, Ruth
    Burzlaff, Kari E.
    Petit, Susan
    Barnes, Meghan
    Torres, Salina
    Snippes Vagnone, Paula M.
    Beall, Bernard
    Pilishvili, Tamara
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (02) : 342 - 351
  • [4] The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy
    Boccia, D
    Alegiani, SS
    Pantosti, A
    Moro, ML
    Traversa, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (02) : 115 - 119
  • [5] Streptococcus pneumoniae:: Description of the pathogen, disease epidemiology, treatment, and prevention
    Bridy-Pappas, AE
    Margolis, MB
    Center, KJ
    Isaacman, DJ
    [J]. PHARMACOTHERAPY, 2005, 25 (09): : 1193 - 1212
  • [6] Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
    Butler, Christopher C.
    Dorward, Jienchi
    Yu, Ly-Mee
    Gbinigie, Oghenekome
    Hayward, Gail
    Saville, Benjamin R.
    Van Hecke, Oliver
    Berry, Nick
    Detry, Michelle
    Saunders, Christina
    Fitzgerald, Mark
    Harris, Victoria
    Patel, Mahendra G.
    de Lusignan, Simon
    Ogburn, Emma
    Evans, Philip H.
    Thomas, Nicholas P. B.
    Hobbs, F. D. Richard
    Allen, Julie
    Andersson, Monique
    Bongard, Emily
    Borek, Aleksandra
    Butler, Christopher C.
    Ferreira, Filipa
    Gbinigie, Oghenekome
    Grabey, Jenna
    Hobbs, F. D. Richard
    Hopkins, Susan
    Judge, David
    Koshkouei, Mona
    Llewelyn, Martin J.
    Richards-Doran, Dan
    Rutter, Heather
    Swayze, Hannah
    Tripathy, Manasa
    Tonkin-Crine, Sarah
    Tonner, Sharon
    [J]. LANCET, 2021, 397 (10279) : 1063 - 1074
  • [7] Core Team R., 2023, A language and environment for statistical computing
  • [8] Impact of conjugate pneumococcal vaccines on antibiotic resistance
    Dagan, Ron
    Klugman, Keith P.
    [J]. LANCET INFECTIOUS DISEASES, 2008, 8 (12) : 785 - 795
  • [9] Di Pasquale M, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720058
  • [10] eucast, About us